Chemical Compound

cabergoline

CAS Registry Number 81409-90-7

Back to search Request a Quote

Primary Record

cabergoline

In stock: 5,882 g
Purity: 98.5 %
CAS: 81409-90-7

Compound Identifiers & Properties

CAS: 81409-90-7
PubChem CID: 54746
SMILES: CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
Canonical SMILES: C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21

Names & Synonyms

cabergoline
Dostinex
Cabaser
Cabergolina
Cabergolinum
Cabaseril
Galastop
Velactis
81409-90-7
Cabergolinum [Latin]
Sogilen
Cabergolina [Spanish]
Caberlin
Cabergoline RS
Cabergoline CRS
Dostinex (TN)
Cabaser (TN)
Neutral Violet Bl
FCE-21336
Cabergoline (Standard)
RefChem:57300
FCE 21336
CABERGOLINE [MI]
Cabergoline [USAN:BAN:INN]
CABERGOLINE [INN]
CABERGOLINE [JAN]
LL60K9J05T
UNII-LL60K9J05T
C26H37N5O2
CABERGOLINE [USAN]
DTXSID6022719
D04EGX
GTPL37
CABERGOLINE [VANDF]
AC1L1HO0
AC1Q5OQ0
CHEBI:3286
DTXCID502719
CABERGOLINE [MART.]
CG-101
SCHEMBL42292
CABERGOLINE [USP-RS]
CABERGOLINE [WHO-DD]
BIDD:GT0775
Cabergoline (JAN/USAN/INN)
Cabergoline [USAN:INN:BAN]
MFCD00867887
orb1308504
Cabergoline (JP18/USP/INN)
Cabergoline [USAN:USP:INN:BAN]
CHEMBL1201087
SCHEMBL29379722
Cabergoline, >=98% (HPLC)
CTK8F8406
BRN 6020775
CABERGOLINE [ORANGE BOOK]
G02CB03
MSK1661
N04BC06
KORNTPPJEAJQIU-KJXAQDMKSA-N
CABERGOLINE [EP MONOGRAPH]
HMS2090A09
HMS3886H05
CABERGOLINE [USP MONOGRAPH]
CID54746
ZINC3800008
Tox21_112589
BDBM50426497
EBC-27129
HY-15296R
s5842
AKOS015961587
C26-H37-N5-O2
Tox21_112589_1
CS-2804
DB00248
FD19622
CABERGOLINE [EMA EPAR VETERINARY]
NCGC00167821-01
NCGC00344544-01
AC-26126
AN-36255
BC207368
HY-15296
K450
LS-64370
MS-28208
SC-19831
Cabergoline 1000 microg/mL in Acetonitrile
CAS-81409-90-7
J134.029H
B3541
NS00001091
1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
A13844
C08187
D00987
F17353
AB01275484-01
409C907
A852993
EN300-19767804
Q423308
SR-05000001493
1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea
SR-05000001493-1
SR-05000001493-2
BRD-K86882815-001-01-6
BRD-K86882815-001-03-2
(6aR,9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
(8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide
1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate
Cabergoline, European Pharmacopoeia (EP) Reference Standard
(8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide
Ergoline-8beta-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-
Cabergoline, United States Pharmacopeia (USP) Reference Standard
ETHYL4-METHYL-2-PYRIDIN-3-YL-1,3-THIAZOLE-5-CARBOXYLATE
(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
(8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide
(8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide
1-[3-(dimethylamino)propyl]-3-ethyl-1-{[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]carbonyl}urea
Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-beta)-
(8R)-6-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)ergoline-8-carboxamide
1-((6-allylergoline-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
1-[(6-allylergolin-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
1-Ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'beta-carbonyl)urea
6-allyl-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-ergoline-8beta-carboxamide
N-(Ethylcarbamoyl)-N-[3-(dimethylamino)propyl]-6-allylergoline-8beta-carboxamide
N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-allyl-ergoline-8beta-carboxamide
(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
(8-beta)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propen-1-yl)ergoline-8-carboxamide
(8?)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl] -6-(2-propen-1-yl)-ergoline-8-carboxamide
(8beta)-N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-ergoline-8-carboxamide
(8R)-6-(2-Propenyl)-8-[[(ethylaminocarbonyl)[3-(dimethylamino)propyl]amino]carbonyl]ergoline
1-(3-(dimethylamino)propyl)-3-ethyl-1-(((2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),9,12,14-tetraen-4-yl)carbonyl)urea
1-(3-(dimethylamino)propyl)-3-ethyl-1-((2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),9,12,14-tetraene-4-carbonyl)urea
1-[3-(dimethylamino)propyl]-3-ethyl-1-[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carbonyl]urea
1-[3-(dimethylamino)propyl]-3-ethyl-1-[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carbonyl]urea
1-[3-(dimethylamino)propyl]-3-ethyl-1-[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carbonyl]urea
Cabergoline; 1-Ethyl-3-[3-(dimethylamino)propyl]-3-[[(6aR,9R,10aR)-7-(prop-2-enyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]carbonyl]urea
Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-
ERGOLINE-8.BETA.-CARBOXAMIDE, N-(3-(DIMETHYLAMINO)PROPYL)-N-((ETHYLAMINO)CARBONYL)-6-(2-PROPENYL)-
N-[3-(Dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8beta-carboxamide
N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)ergoline-8beta-carboxamide